期刊文献+

Survivin和PTEN在非小细胞肺癌中的表达及相关性研究 被引量:2

Expression and correlation of survivin and PTEN in non-small cell lung cancer
下载PDF
导出
摘要 目的:探讨survivin和PTEN在非小细胞肺癌(NSCLC)中的表达情况及其与NSCLC临床生物学行为的关系。方法:应用免疫组织化学方法检测survivin和PTEN在78例NSCLC组织、46例癌旁组织和12例非癌肺良性病变组织中的表达情况,并将结果进行相关性分析。结果:Survivin在非癌良性病变组织、癌旁组织、非小细胞肺癌中的阳性表达率分别是0、10.9%、67.9%,其蛋白表达逐渐增强(P<0.05);非小细胞肺癌中的survivin表达显著高于癌旁肺组织及非癌良性病变组织中的表达(P<0.05)。PTEN在非癌良性病变组织、癌旁组织、非小细胞肺癌中的阳性表达率分别是100%、91.3%、47.4%,其表达逐渐减弱(P<0.05);非小细胞肺癌中的PTEN表达低于癌旁肺组织及非癌良性病变组织中的表达(P<0.05)。survivin蛋白的表达与NSCLC的病理学分级、淋巴结转移、TNM分期有关(P<0.05)。PTEN蛋白的表达与NSCLC的病理学分级、淋巴结转移、TNM分期有关(P<0.05)。Survivin与PTEN表达呈负相关(P<0.05)。结论:Survivin和PTEN在NSCLC中的异常表达与其生物学行为密切相关,survivin在非小细胞肺癌中过度表达,PTEN在非小细胞肺癌中表达降低,并且二者的表达呈负相关,二者可作为NSCLC判断病情和评价预后的参考指标。 Objective: To study the expression of survivin and PTEN in non-small cell lung cancer (NSCLC) and to investigate their correlations with the biological behavior of NSCLC. Methods: Expression of survivin and PTEN proteins was detected by immunohistochemical assay in 78 NSCLC tissues, 46 lung cancer adjacent tissues and 12 benign lung tissues, which entailed subsequent analysis on the correlation. Results: The expression rate of survivin was the lowest in benign lung tissues (0%), followed by the adjacent tissues ( 10. 9% ) and NSCLC tissues (67.9%) ( both P 〈 0.05 ). The expression rate of PTEN was the highest in benign lung tissues ( 100% ) , followed by the adjacent tissues (91.3%) and NSCLC tissues (47.4%) ( both P 〈0. 05 ). The expression of survivin and PTEN was associated with the pathological grading, lymph node metastases and TNM stages ( all P 〈 0.05 ). Furthermore, the expression of survivin correlated negatively with that of PTEN ( P 〈 0.05 ). Conclusion : The aberrant expression of survivin and PTEN in NSCLC may be associated with their biological behaviors. Survivin is over expressed whilst PTEN is down-regulated in NSCLC. Survivin expression correlates negatively with PTEN expression. Both markers could serve as the reference for determination of the disease severity and evaluation of the prognosis of NSCLC.
出处 《广州医学院学报》 2013年第6期1-5,共5页 Academic Journal of Guangzhou Medical College
基金 广东省第一批科学事业费计划项目(2008B030301018)
关键词 非小细胞肺癌 SURVIVIN PTEN 免疫组织化学 non-small cell lung cancer survivin PTEN immunohistochemistry
  • 相关文献

参考文献22

  • 1Jemal A, Siegel R, Ward E, et al. Thun MJ. Cancer statistics[ J]. CA Cancer J Clin, 2009, 59(4) :225-249.
  • 2Srinivasula SM, Ashwell JD. lAPs: what's in a name[ J]. Mol Cell, 2008, 30 ( 2 ) : 123-135.
  • 3Hernandez JM, Farina JM, Coppola D, et al. Expression of the antiapoptotic protein snrvivin in colon cancer[J]. Clin Colorectal Cancer, 2011, 10(3) :188-193.
  • 4Pavlyukov MS, Antipova NV, Balashova MV, et al. Shakhparonov MI. Survivin monomer plays an essential role in apoptosis regulation[J]. J Biol Chem, 2011, 286 ( 26 ) :23296-23307.
  • 5Al-Saad S, Donnem T, Al-Shibli K, et al. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cellsand stromal compartment in non-small cell lung cancer [ J ]. Anticancer Res, 2009,29 ( 10 ) :4175-4183.
  • 6Falleni M, Pellegrini C, Marehetti A, et al. Survivin gene expression in early-stage non small cell lung cancer[ J]. J Pathol.2003.200(5 ) :620 -626.
  • 7Karczmarek-Borowska B, Filip A, Wojcierowski J, et al. Survivin anti-apoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study [ J]. Folia Histochem Cytobiol, 2005, 43 (4) : 237- 242.
  • 8Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers [ J ]. J Clin Oncol, 1999, 17(7) : 2100-2104.
  • 9Sarela AI, Macadam RCA, Farmery SM, et al. Expression of the anti-apoptosis gene, survivin, predicts death from recurrent colorectal carcinoma [ J ]. Gut, 2000, 46 (5) : 645 -650.
  • 10Visehioni B, van der Valk P, Span SW, et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small cell lung cancer [ J]. Ann Oncol, 2004, 15(11): 1654-1660.

二级参考文献7

  • 1王东,史景泉,柳凤轩.人肝细胞癌p53蛋白免疫组化研究[J].第三军医大学学报,1997,19(2):119-121. 被引量:7
  • 2Sano T,Lin H,Chen X,et al.Differential expression of MMAC/PTEN in glioblastoma multiform: relationship to localization and prognosis[].Cancer Research.1999
  • 3Hahn SA,Hoque AT,Moskaluk CA,et al.Homozygous deletion map at 18q21. 1 in pancreatic cancer[].Cancer Research.1996
  • 4Markowitz SD,Robert AB.Tumor suppressor activity of the TGF-beta pathway in human cancer[].Cytokine and Growth Factor Reviews.1996
  • 5Li J,Yen C,Liaw D,et al.PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[].Science.1997
  • 6Atfi A,Buisine M,Mazars A,et al.Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/C-jun N-terminal kinase ( SAPK/JNK)signaling pathway[].Journal of Biological Chemistry.1997
  • 7肖恩华.肿瘤浸润转移的分子生物学机制[J].国外医学(临床放射学分册),2000,23(6):335-340. 被引量:7

共引文献34

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部